Suresh Kumar

Title: Innovations of Suresh Kumar in Anticancer Research

Introduction

Suresh Kumar is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of three patents to his name, his work focuses on innovative compounds that target critical pathways in cancer progression.

Latest Patents

One of Suresh Kumar's latest patents involves the development of 1,3,5-triazine based PI3K inhibitors as anticancer agents. This invention describes heterocyclic compounds of general Formula 1, which inhibit phosphoinositide 3-kinase (PI3K) and can be utilized as effective anticancer agents. Another significant patent pertains to Rohitukine analogs as cyclin-dependent kinase inhibitors. This invention relates to the rohitukine analogs of formula A and their pharmaceutically acceptable salts. The compounds are designed to treat or prevent various proliferative disorders, including melanoma, leukemia, breast cancer, and prostate cancer.

Career Highlights

Suresh Kumar is affiliated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of cancer treatment options through innovative chemical compounds.

Collaborations

Suresh Kumar collaborates with esteemed colleagues such as Ram Asrey Vishwakarma and Dilip Manikrao Mondhe. Their combined expertise enhances the research efforts and contributes to the successful development of new therapeutic agents.

Conclusion

Suresh Kumar's innovative work in the field of anticancer research exemplifies the impact of dedicated inventors in the scientific community. His patents reflect a commitment to finding effective solutions for cancer treatment, showcasing the importance of innovation in medicine.